Related Experiment Videos
Circulating alpha-actin protein in acute myocardial infarction
A E Aránega1, A Reina, M A Muros
1Department of Morphological Sciences, School of Medicine, University of Granada, Spain.
International Journal of Cardiology
|January 1, 1993
Summary
Cardiac alpha-actin, a contractile protein, is present in the bloodstream of most acute myocardial infarction patients. This biomarker aids in understanding heart attacks and their associated factors.
Area of Science:
- Biochemistry
- Cardiology
- Molecular Biology
Background:
- Acute myocardial infarction (AMI) diagnosis relies on clinical, ECG, and enzyme markers.
- The presence and significance of circulating contractile proteins in AMI require further investigation.
Purpose of the Study:
- To investigate the presence of cardiac alpha-actin in the blood of AMI patients.
- To determine the diagnostic utility of circulating alpha-actin in AMI.
Main Methods:
- Western-blot analysis using a monoclonal antibody specific for cardiac alpha-actin.
- Analysis of blood samples from 70 AMI patients, 70 healthy controls, and 30 patients with skeletal muscle damage.
Main Results:
- Circulating alpha-actin was detected in 95% of AMI patients (67/70) as a 43 kDa band.
- Alpha-actin was largely absent in healthy controls (98% negative) and patients with skeletal muscle damage.
- Highest concentrations were observed in anterior AMI; detection occurred 1-180 hours post-onset with a biphasic pattern.
Conclusions:
- Circulating cardiac alpha-actin is a sensitive biomarker for acute myocardial infarction.
- Serum alpha-actin levels correlate with AMI subtype, sex, tobacco use, and complications.
- This protein offers potential for deeper understanding of AMI pathophysiology and clinical management.